In the News
Reimagine Care and Tampa General Hospital Cancer Institute Launch Virtual Cancer Care Collaboration to Reduce Hospitalizations and Elevate Patient Support
Technology-enabled cancer care provider Reimagine Care recently announced that it has entered into a collaboration with the Tampa General Hospital (TGH) Cancer Institute, in which the two will be expanding access and increasing quality of care for oncology treatment throughout Tampa Bay, Florida. This will be...
Midi Health CEO Joanna Strober Discusses Accessible Menopause Care with McKesson Ventures Partner Michelle Snyder on Breaking Health Podcast
Joanna Strober, CEO and founder of women’s midlife care provider Midi Health, recently was featured on Episode 176 of the Breaking Health Podcast, alongside host and McKesson Ventures partner Michelle Snyder. The two discussed how Midi is providing a platform for robust and equitable healthcare to women all across...
Atropos Health Launches the Atropos Evidence™ Agent with Microsoft Teams to Surface Personalized Evidence during Multidisciplinary Care Team Collaborations
Real-world data-based healthcare technology company Atropos Health recently announced the launch of an integration between the company’s Atropos Evidence™ Agent and Microsoft Teams. This agent allows for real-world evidence (RWE) to be generated at the touch of a button—to be used by medical providers to gain...
Saama Unveils Industry-first AI-Powered Tables, Listings, and Figures (TLF) Analyzer to Transform Clinical Study Reporting
AI-driven life science services and solutions company Saama recently announced the launch of its Tables, Listings, and Figures (TLF) Analyzer — a system that uses Saama’s AI-powered document generation and multi-modal GenAI models to interpret and summarize complex clinical data. This will help to increase workflow...
McKesson Ventures Announces Expansion Into Growth Equity and Welcomes Peter Lafer as Head of Growth Investing
In this newly created role, Peter will focus on building and leading a dedicated effort on investments in high-growth and profitable businesses. “We are thrilled to welcome Peter to the McKesson Ventures team,” said Dave Schulte, President of McKesson Ventures. “We are proud to have one of the most comprehensive...
Oath Surgical Raises $24M to Build the First Surgeon-Owned, AI-Powered Surgical System
AI-powered surgical care innovator Oath Surgical recently announced that it has secured $24 million in Series A funding, led by FPV Ventures alongside McKesson Ventures and existing investors OSE, Black Opal Ventures, Tau Ventures, and Rogue VC — bringing the company’s total funding thus far to $35 million. Oath...
Lumata Health Improves Patient Adherence to Vision-Saving Treatments by Alleviating Barriers to Care
Ophthalmology and optometry management provider Lumata Health recently announced the results of its new research report “Lumata’s Continuous Care Program Demonstrates Increased Appointment Attendance by Addressing Barriers to Care.” This report found that patients who used the Lumata Health Continuous Care model...
Saama Introduces Modular and Adaptive AI Agents For Clinical Innovation
AI-driven solutions and services provider Saama has announced the introduction of Clinical AI Agents — a modular, industry-first approach to rapidly increase innovation and efficiency for existing platform investments. These Clinical Agents, developed using Saama’s existing Agentic AI platform, are designed to...
Komodo Health Introduces Marmot, the AI Built to Accelerate Healthcare Innovation
AI-powered healthcare intelligence company Komodo Health has announced the launch of Marmot™—a healthcare-native AI engine that uses healthcare analytics and real-world data to provide actionable insights to Life Sciences and healthcare teams within minutes. This greatly improves the speed at which these teams are...
Atropos Health Enters into Strategic Collaboration to Reduce Time to Rare Disease Diagnosis with Artificial Intelligence (AI) Algorithm
On Monday, August 18th, real-world clinical data company Atropos Health announced that it has partnered with innovative medicines company Novartis to help train and improve medical AI models used to detect paroxysmal nocturnal hemoglobinuria (PNH). This rare disease is a blood disorder that can present with a variety...